New combination antiviral for the treatment of hepatitis C-Reference-Cited by-同舟云学术

New combination antiviral for the treatment of hepatitis C

Published:2016-07-15 Issue:14 Volume:73 Page:1042-1050
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Lam Jerika T.¹,Salazar Laura²

Affiliation:

1. Department of Pharmacy Practice, Chapman University School of Pharmacy, Irvine, CA

2. Hoag Affiliated Physicians Group, Newport Beach, CA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/73/14/1042/28450045/ajhp1042.pdf

Reference51 articles.

1. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource;Smith;Hepatology,2014

2. An overview about hepatitis C: a devastating virus;Bostan;Crit Rev Microbiol,2010

3. World Health Organization. Global alert and response: hepatitis C. www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index2.html (accessed 2015 Jan 25).

4. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection;McHutchison;N Engl J Med,2009

5. Antiviral therapy for chronic hepatitis C: past, present, and future;Hayashi;J Gastroenterol,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-aided molecular modeling and design studies of some N-(4-(dimethyl amino) phenyl)-4-methoxy-3-propionamidobenzamide derivatives as NS5B polymerase inhibitors;The Microbe;2024-09

2. Overcoming Bioavailability Challenges of Dasabuvir and Enabling a Triple-Combination Direct-Acting Antiviral HCV Regimen through a Salt of Very Weak Acid for Oral Delivery;Molecular Pharmaceutics;2022-04-28

3. Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus;European Journal of Medicinal Chemistry;2022-01

4. Discovery and Development of Metal-Catalyzed Coupling Reactions in the Synthesis of Dasabuvir, an HCV-Polymerase Inhibitor;The Journal of Organic Chemistry;2019-01-10